NASDAQ: NIVF
Newgenivf Group Ltd Earnings Dates, Reports, Calls

Newgenivf Group earnings were $9.9M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest NIVF earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$7.7M, down 145.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, NIVF reported annual earnings of $9.9M, with -1,983.1% growth.

NIVF past earnings growth

How has NIVF's earnings growth performed historically?

Company
N/A
Industry
28.93%
Market
90.49%
NIVF's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
NIVF's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

NIVF earnings history

Current Revenue
$4.7M
Current Earnings
$9.9M
Current Profit Margin
209%

NIVF Return on Equity

Current Company
77.2%
Current Industry
-62%
Current Market
28.9%
NIVF's Return on Equity (77.2%)... subscribe to Premium to read more.
High Return on Equity Performance

NIVF Return on Assets

Current Company
54.4%
Current Industry
7.7%
NIVF is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NIVF announces earnings.

NIVF Return on Capital Employed

Current Company
34.58%
Current Industry
19.1%
NIVF's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NIVF vs Medical Care Facility Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NIVF$11.00M$9.88M-99.95%$214.73
BMGL-$7.60M-$8.36MN/A-$0.45
AMS$5.57M-$1.55MN/A-$0.23
CCM$32.26M-$13.61MN/A-$3.12
PIII-$6.73M-$147.95MN/A-$45.26

Newgenivf Group Earnings Reports & History FAQ

What were Newgenivf Group's earnings last quarter?

Newgenivf Group (NASDAQ: NIVF) reported Q4 2025 earnings per share (EPS) of -$946.27, up 51.19% year over year. Total NIVF earnings for the quarter were -$7.67 million. In the same quarter last year, Newgenivf Group's earnings per share (EPS) was -$1,938.76.

If you're new to stock investing, here's how to buy Newgenivf Group stock.

Is Newgenivf Group profitable or losing money?

As of the last Newgenivf Group earnings report, Newgenivf Group is currently profitable. Newgenivf Group's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $9.88 million, a 1,983.07% decrease year over year.

What was NIVF's earnings growth in the past year?

As of Newgenivf Group's earnings date in Q2 2026, Newgenivf Group's earnings has grown year over year. NIVF earnings in the past year totalled $9.88 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.